Through this partnership, Inotiv will integrate VUGENE’s cloud-based bioinformatics and computational platform into its Discovery & Translational Sciences Division, enabling a more efficient and ...
The disaster that struck John Quackenbush and his lab at the Harvard T.H. Chan School of Public Health began when the Trump ...
Original publication in Cancer Cell: A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myeloma. DOI: ...
John Quackenbush built a lab that is at the forefront of human genetics research and bioinformatics. Trump administration ...
Dispersing federal research funding, largely concentrated at private universities on the coasts, to the rest of the country ...
In multiple myeloma, plasma cells proliferate uncontrollably in the bone marrow, disrupting the growth of healthy blood-forming cells. If the disease ...
In multiple myeloma, plasma cells proliferate uncontrollably in the bone marrow, disrupting the growth of healthy ...
UB spinout Auspex Medix advances AI-powered hearing test to help older adults thwart cognitive decline, Alzheimer’s and more.
Amid NIH funding delays, reversals and uncertainty, a scientist at Harvard who studies breast cancer has lost one-third of ...
Dr Ryan Magee graduates today with a PhD in Biological Sciences, having developed a faster, cheaper method to track a major ...
Discover how the Impact of R&D on Biotech Companies in India is driving innovation, boosting exports and transforming pharma, ...
According to Mordor Intelligence, the global exosomes market is valued at USD 0.71 billion in 2025 and is projected to surpass USD 2.21 billion by 2030, at a 25.5% CAGR during 2025-2030. The market is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback